Featured News
Press Release
Strong Bipartisan Support for Continued Investment in Alzheimer’s Research on Full Display During Senate Appropriations Hearing
Senate appropriators from both sides of the aisle raise warnings of harm that would come from proposed research funding and staff cuts Washington, D.C., April 30, 2025 — During today’s Senate Appro...
All News
Press Release
House Introduces Bipartisan Legislation to Renew BOLD Commitment to Dementia Public Health Infrastructure
Washington, D.C., February 5, 2024 — Today, the House began renewing our nation’s commitment to strengthening the dementia public health...
AIM Blog
Recognizing AIM’s February Advocate of the Month: Pamela Talley
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Biogen’s Decision to Discontinue Alzheimer’s Drug
CHICAGO, Jan. 31, 2024 — Despite today’s announcement from Biogen, the Alzheimer’s Association is extremely optimistic about the future of...
AIM Blog
To Improve the Early Detection and Diagnosis of Alzheimer’s, States Need to Ensure Access to Biomarker Testing
With the historic Food and Drug Administration (FDA) approval of treatments that slow the progression of Alzheimer’s in the early...
AIM Blog
Recognizing AIM’s January Advocate of the Month: Mary Dysart Hartt
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
AIM Blog
State Spotlight: South Carolina
Thanks to our dedicated advocates in all 50 states, AIM is leading the way to advance legislation to improve the...